These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9653621)

  • 1. Factor V Leiden (F5 Q506) and vascular disease in Canadian Oji-Cree.
    Hegele RA; Harris SB; Cao H; Hanley AJ; Zinman B
    Diabetes Care; 1998 Jul; 21(7):1203. PubMed ID: 9653621
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to factor V Leiden in Mexico.
    Majluf-Cruz A
    Clin Appl Thromb Hemost; 2009; 15(4):478. PubMed ID: 19726420
    [No Abstract]   [Full Text] [Related]  

  • 3. Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers.
    Hegele RA; Sun F; Harris SB; Anderson C; Hanley AJ; Zinman B
    J Hum Genet; 1999; 44(1):10-4. PubMed ID: 9929969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Arg506 --> Gln mutation (factor V Leiden) in Pima Indians.
    Kohler HP; Boothby M; McCormack L; Knowler WC; Grant PJ
    Thromb Haemost; 1997 Aug; 78(2):961-2. PubMed ID: 9268205
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population.
    Pollex RL; Hanley AJ; Zinman B; Harris SB; Hegele RA
    Int J Obes (Lond); 2006 Mar; 30(3):484-91. PubMed ID: 16276364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F5 Q506 mutation and the low prevalence of cardiovascular disease in Canadian Inuit.
    Mandelcorn R; Connelly PW; Boright A; Young TK; Hegele RA
    J Investig Med; 1998 Jun; 46(5):232-5. PubMed ID: 9676056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene symbol: F5. Disease: F5 type I.
    Hongli W
    Hum Genet; 2006 Jul; 119(6):676. PubMed ID: 17128470
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree.
    Hegele RA; Harris SB; Zinman B; Hanley AJ; Cao H
    Diabetes Care; 2001 Aug; 24(8):1498-9. PubMed ID: 11473094
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation.
    Kim YJ; Williamson RA; Murray JC; Andrews J; Pietscher JJ; Peraud PJ; Merrill DC
    Am J Obstet Gynecol; 2001 May; 184(6):1211-7. PubMed ID: 11349190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary thrombophilia in Mexico IV: frequency of the Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic Mexican Mestizo patients.
    Ruiz-Argüelles GJ; Poblete-Naredo I; Reyes-Núñez V; Garcés-Eisele J; López-Martínez B; Gómez-Rangel JD
    Rev Invest Clin; 2004; 56(5):600-4. PubMed ID: 15776863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R255h amino acid substitution of protein Z identified in patients with factor V Leiden mutation.
    Kemkes-Matthes B; Matthes KJ; Souri M; Koseki-Kuno S; Ichinose A
    Br J Haematol; 2005 Jan; 128(2):248-52. PubMed ID: 15638861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of cardiovascular risk factors in two separate but genetically-comparable populations.
    Axelsson J; Karlsson M; Petursdottir G; Asgeirsdottir AG; Olafsson O; Sigfusson N; Way AB; Sigvaldason H; Sigurdsson SB
    Arctic Med Res; 1991; Suppl():509-11. PubMed ID: 1365208
    [No Abstract]   [Full Text] [Related]  

  • 13. [[The importance of studying factor V Leiden and the 20210 [correction of 29210A] allele of the prothrombin gene in thromboembolic disease].
    Batlle J; López Fernández MF
    Sangre (Barc); 1999 Feb; 44(1):3-6. PubMed ID: 10323089
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes.
    Pollex RL; Hanley AJ; Zinman B; Harris SB; Khan HM; Hegele RA
    Diabet Med; 2005 Nov; 22(11):1510-5. PubMed ID: 16241915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate gene approach in association studies: would the factor V Leiden mutation have been found by this approach?
    van Hylckama Vlieg A; Sandkuijl LA; Rosendaal FR; Bertina RM; Vos HL
    Eur J Hum Genet; 2004 Jun; 12(6):478-82. PubMed ID: 15054398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
    Cooley BC; Chen CY; Schmeling G
    Thromb Res; 2007; 119(6):747-51. PubMed ID: 16793123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A BRCA1 mutation in Native North American families.
    Liede A; Jack E; Hegele RA; Narod SA
    Hum Mutat; 2002 Apr; 19(4):460. PubMed ID: 11933205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.
    Fogli A; Wong K; Eymard-Pierre E; Wenger J; Bouffard JP; Goldin E; Black DN; Boespflug-Tanguy O; Schiffmann R
    Ann Neurol; 2002 Oct; 52(4):506-10. PubMed ID: 12325082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
    Reitsma PH; van de Stolpe A
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of factor V Leiden mutation (Arg506Gln) and anticardiolipin antibodies in migraine patients.
    Intiso D; Crociani P; Fogli D; Grandone E; Cappucci G; Di Rienzo F; Di Viesti P; Simone P; Tonali P
    Neurol Sci; 2002 Mar; 22(6):455-8. PubMed ID: 11976977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.